Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes

OMICS A Journal of Integrative Biology

Volumn 15, Issue 6, 2011, Pages 409-418

  Mojtahedi, Zahra ^a   Safaei, Akbar ^b   Yousefi, Zahra ^a   Ghaderi, Abbas ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; ANGIOGENIN; ELECTRON TRANSFERRING FLAVOPROTEIN; ENOLASE; ENOLASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; EUKARYOTIC TRANSLATION INITIATION FACTOR 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INITIATION FACTOR; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; NUCLEOPHOSMIN; PEROXIREDOXIN 6; PHOSPHATASE; PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOHISTIDINE PHOSPHATASE 1 ISOFORM 3; PHOSPHOPROTEIN; PROHIBITIN; PROTEASOME; PROTEIN 14 3 3; PROTEIN PHOSPHATE 2A REGULATORY SUBUNIT; PROTEOME; RIBONUCLEASE INHIBITOR; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ANTIGENICITY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL CULTURE; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; TUMOR IMMUNOLOGY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROTEOME; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 79958706584     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0131     Document Type: Article

References (32)

1. Benavides, L.C., Gates, J.D., Carmichael, M.G., Patil, R., Holmes, J.P., Hueman, M.T., et al. (2009). The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02. Clin Cancer Res 15, 895-904.
2. Brankin, B., Skaar, T.C., Brotzman, M., Trock, B., and Clarke, R. (1998). Autoantibodies to the nuclear phosphoprotein nu-cleophosmin in breast cancer patients. Cancer Epidemiol Biomarkers Prev 7, 1109-1115. (Pubitemid 29001667)
3. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G.M., Carnemolla, B., et al. (2004). Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327-1333. (Pubitemid 38801651)
4. Chang, G.C., Liu, K.J., Hsieh, C.L., Hu, T.S., Charoenfuprasert, S., Liu, H.K., et al. (2006). Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 12, 5746-5754. (Pubitemid 44629605)
5. Chen, X., Fu, S., Chen, F., Chen, H., and Chen, Z. (2008). Identification of tumor-associated antigens in human hepatocel-lular carcinoma by autoantibodies. Oncol Rep 20, 979-985.
6. Conroy, S.E., Sasieni, P.D., Amin, V., Wang, D.Y., Smith, P., Fentiman, I.S., et al. (1998). Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer 77, 1875-1879. (Pubitemid 28254627)
7. Diaz-Ruiz, R., Rigoulet, M., and Devin, A. The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta 2010 Sep 8 [Epub ahead of print].
8. Dickson, K.A., Kang, D.K., Kwon, Y.S., Kim, J.C., Leland, P.A., Kim, B.M., et al. (2009). Ribonuclease inhibitor regulates neovascularization by human angiogenin. Biochemistry 48, 3804-3806.
9. Dougherty, M.K., and Morrison, D.K. (2004). Unlocking the code of 14-3-3. J Cell Sci 117, 1875-1884. (Pubitemid 38745122)
10. Dupire, S., and Coiffier, B. (2010). Targeted treatment and new agents in diffuse large B cell lymphoma. Int J Hematol 92, 12-24.
11. Gonzalez-Angulo, A.M., Morales-Vasquez, F., and Hortobagyi, G.N. (2007). Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608, 1-22.
12. Hamrita, B., Chahed, K., Kabbage, M., Guillier, C.L., Trimeche, M., Chaieb, A., et al. (2008). Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). Clin Chim Acta 393, 95-102.
13. Hamsher, C., Smith, A.M., Dehqanzada, Z.A., Khoo, S., Ponniah, S., Peoples, G.E., et al. (2007). Pattern of serum immunoreac-tivity against breast cancer cell lysates may predict severity of disease in breast cancer patients. Cancer Immunol Immun-other 56, 1711-1721. (Pubitemid 47313076)
14. Kadkol, S.S., El Naga, G.A., Brody, J.R., Bai, J., Gusev, Y., Dooley, W.C., et al. (2001). Expression of pp32 gene family members in breast cancer. Breast Cancer Res Treat 68, 65-73. (Pubitemid 32928272)
15. Kim, S., Cho, H., Nam, E.J., Kim, S.W., Kim, Y.T., Park, Y.W., et al. (2010). Autoantibodies against stress-induced phospho-protein-1 as a novel biomarker candidate for ovarian cancer. Genes Chromosomes Cancer 49, 585-595.
16. Kuramitsu, Y., and Nakamura, K. (2006). Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics 6, 5650-5661. (Pubitemid 44683228)
17. Medeiros, L.R., Rosa, D.D., Da Rosa, M.I., and Bozzetti, M.C. (2009). Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol 142, 99-105.
18. Nakanishi, T., Takeuchi, T., Ueda, K., Murao, H., and Shimizu, A. (2006). Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. J Chromatogr B Anal Technol Biomed Life Sci 838, 15-20. (Pubitemid 43832210)
19. Olson, J.E., Wang, X., Pankratz, V.S., Fredericksen, Z.S., Vachon, C.M., Vierkant, R.A., et al. (2011). Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat 125, 221-228.
20. Ou, K., Yu, K., Kesuma, D., Hooi, M., Huang, N., Chen, W., et al. (2008). Novel breast cancer biomarkers identified by integra-tive proteomic and gene expression mapping. J Proteome Res 7, 1518-1528.
21. Philip, R., Murthy, S., Krakover, J., Sinnathamby, G., Zerfass, J., Keller, L., et al. (2007). Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer. J Proteome Res 6, 2509-2517. (Pubitemid 47122348)
22. Pollari, S., Kakonen, S.M., Edgren, H., Wolf, M., Kohonen, P., Sara, H., et al. (2011). Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res Treat 125, 421-430.
23. Purdie, C.A., Bake, R.L., Ashfield, A., Chatterjee, S., Jordan, L.B., Quinlan, P., et al. (2010) Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study. Br J Cancer 103, 475-481.
24. Shukla, S., Pranay, A., D'Cruz, A.K., Chaturvedi, P., Kane, S.V., and Zingde, S.M. (2009). Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark 5, 127-135.
25. Silvera, D., Formenti, S.C., and Schneider, R.J. (2010). Transla-tional control in cancer. Nat Rev Cancer 10, 254-266.
26. Tamesa, M.S., Kuramitsu, Y., Fujimoto, M., Maeda, N., Naga-shima, Y., Tanaka, T., et al. (2009). Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. Electro-phoresis 30, 2168-2181.
27. Tan, L., Fu, X.Y., Liu, S.Q., Li, H.H., Hong, Y., Wu, M.C., and Wang, H.Y. (2005). Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma. Liver Int 25, 667-676. (Pubitemid 40861916)
28. Wong, L.L., Zhang, D., Chang, C.F., and Koay, E.S. (2010). Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis. Exp Cell Res 316, 3387-3396.
29. Yan, H., Parsons, D.W., Jin, G., McLendon, R., Rasheed, B.A., Yuan, W., et al. (2009). IDH1 and IDH2 mutations in gliomas. N Engl J Med 360, 765-773.
30. Zang, L., Palmer Toy, D., Hancock, W.S., Sgroi, D.C., and Kar-ger, B.L. (2004). Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/ 18O isotopic labeling. J Proteome Res 3, 604-612. (Pubitemid 39207366)
31. Zhang, D., Tai, L.K., Wong, L.L., Chiu, L.L., Sethi, S.K., and Koay, E.S. (2005). Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 4, 1686-1696. (Pubitemid 41749262)
32. Zhu, W.L., Cheng, H.X., Hun, N., Liu, D.L. Zhu, W.X., Fan, B.L., et al. (2008). Messenger RNA expression of translationally controlled tumor protein (TCTp) in liver generation and cancer. Anticancer Res 28, 1575-1580.